Thermo Fisher Scientific’s Clinical Research Business Recognized by ISG for Digital Services Leadership
14 Agosto 2024 - 3:15PM
Business Wire
The PPD clinical research business has been
named a leader in digital solutions and services by ISG for four
consecutive years
The PPD clinical research business of Thermo Fisher Scientific,
the world leader in serving science, has been honored for industry
leadership in digital services by Information Services Group (ISG),
a leading global technology research and advisory firm. The
business was recognized as an ISG Provider Lens Leader for its
digital transformation services in clinical development and patient
engagement, as well as pharmacovigilance and regulatory
affairs.
ISG’s honor focuses on the business’ ability to provide access
to patients to clinical trials of promising new medical therapies
in a more efficient and effective way. It also recognizes the
ability to help pharmaceutical and biotech customers accelerate the
delivery of safe and effective medicines to the marketplace while
addressing issues of patient diversity, health equity and
sustainability in clinical research.
In the 2024 ISG Provider Lens™ Life Sciences Digital Services
Global Report, ISG specifically recognized Thermo Fisher’s clinical
research business for its decentralized trials capabilities,
full-spectrum expertise across various therapeutic areas and
customized, diverse patient engagement solutions. ISG highlighted
the strength of the business’ robust patient recruitment and
retention strategies that continue to overcome common barriers in
clinical trials, such as lack of awareness, access, trust,
inconvenience and socioeconomic challenges.
Additionally, the report highlighted the business’ advanced
disease simulation and modeling, along with its comprehensive
pharmacovigilance and regulatory solutions, which includes
artificial intelligence integration and machine learning. The PPD
clinical research business leverages a diverse range of technology
solutions to propel advancements in areas such as case processing,
safety profiling, regulatory intelligence collection and
compilation.
“We are honored to once again receive this recognition from ISG,
affirming our steadfast market presence and exceptional industry
leadership,” said Brittany Erana, vice president and general
manager, Patient First Digital Solutions, clinical research, Thermo
Fisher Scientific. “We are dedicated to revolutionizing
patient-centered clinical research by harnessing cutting-edge
patient and site-enabling technology, while adopting a
comprehensive approach that prioritizes enhancing the patience
experience. This unwavering commitment to patients empowers us and
our customers to introduce life-changing medicines to the global
market.”
In 2023, Thermo Fisher invested $1.3 billion in research and
development to deliver new technologies across all businesses,
including the PPD clinical research business. For its ISG Provider
Lens report, ISG conducted an independent review of life science
companies offering digital services, then selected the top 20
companies for a deep analysis and placement on its Provider Lens
Quadrant. ISG’s findings cover defined technology and service
categories, as well as industry-specific capabilities.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving
science, with annual revenue over $40 billion. Our Mission is to
enable our customers to make the world healthier, cleaner and
safer. Whether our customers are accelerating life sciences
research, solving complex analytical challenges, increasing
productivity in their laboratories, improving patient health
through diagnostics or the development and manufacture of
life-changing therapies, we are here to support them. Our global
team delivers an unrivaled combination of innovative technologies,
purchasing convenience and pharmaceutical services through our
industry-leading brands, including Thermo Scientific, Applied
Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services,
Patheon and PPD. For more information, please visit
www.thermofisher.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240814919656/en/
Media Contact Information: Nadine Maeser
nadine.maeser@ppd.com